JUN 13, 2016 3:01 PM PDT

Personalized Treatment For People With Depression?

WRITTEN BY: Xuan Pham
Depression affects millions of people worldwide, yet it’s an illness that’s still highly stigmatized. As with many illnesses, some patients respond to treatment and some don’t. But a new research suggests that testing patients for inflammatory biomarkers could reveal those who could benefit from more aggressive medication regimen.
    First of its kind test could personalize depression treatment | pixabay.com
 Clinical depression is different than sadness following a traumatic life event, such as the loss of a loved one. Patients with clinical depression are diagnosed by trained physicians based on criteria set by the Diagnostic and Statistical Manual of Mental Disorders (DSM). Currently, an estimated 14.8 million Americans are afflicted with depression. And as the mental condition is tied to physical wellness, the incidence of depression is ever increasing.
 
Generally, patients with depression are treated with a combination of medication (antidepressants) and psychological counseling. But the success rate of these treatments is variable, and doctors often have to engage through trial and error to arrive at the correct medication dose for their patients. Could blood-borne biomarkers eliminate this trial and error?
 
Based on the belief that inflammation drives stress which interferes with the actions of antidepressants, researchers at the King’s College London wondered whether inflammatory proteins could point to hard-to-treat cases. They looked at 140 people with depression, and isolated two biomarkers of inflammation: macrophage migration inhibitory factor (MIF), and interleukin-1beta.
 
In their study, the researchers found presence of these two biomarkers corresponded with decreased response to treatment. That is, patients with high levels of these proteins were less likely to respond to traditional antidepressants like selective serotonin reuptake inhibitors (SSRIs) and tricyclic compounds.
 

"About a third of patients might have these inflammatory markers and they would be people we might encourage to go on more aggressive treatment," said Carmine Pariante, the senior study author.
 
By contrast, the biomarker could alert doctors to go easy on those who are more likely to respond to the medications. After all, antidepressants may be safe, but they are not without side-effects. "We would not want to go in prescribing too much medicine if it's not necessary, but we would want to escalate people sooner rather than later if they need it," said Pariante.
 
Some caveats of the study include the limited size and the need for validation in a larger clinical trial. But the team is excited, as this is the first study of its kind to point towards personalized therapy for a mental illness like depression. "Being able to target those people with depression who don't respond to medication would be one of the most exciting steps forward in the treatment of mental illness for decades," said Marjorie Wallace, chief executive of SANE, a UK mental health charity organization.

Additional source: BBC
About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 09, 2020
Genetics & Genomics
Potential Problems with Liquid Biopsies
NOV 09, 2020
Potential Problems with Liquid Biopsies
Liquid biopsies are tests that look for biomarkers in the blood, which can help inform the treatment of cancer. The tool ...
DEC 01, 2020
Cardiology
The Benefits of Exercise on Adipokine Levels for Post-Menopausal Women
DEC 01, 2020
The Benefits of Exercise on Adipokine Levels for Post-Menopausal Women
The benefits of a healthy lifestyle don’t just stop when you get older. Being active has been shown to improve pos ...
DEC 03, 2020
Neuroscience
Scientists Invent Noninvasive Microscope to Observe Neurons
DEC 03, 2020
Scientists Invent Noninvasive Microscope to Observe Neurons
To obtain high-resolution images of the brain, researchers usually need to reduce the thickness of the skull or cut into ...
DEC 24, 2020
Clinical & Molecular DX
Feeling Unmotivated? It Could Be Dementia.
DEC 24, 2020
Feeling Unmotivated? It Could Be Dementia.
Apathy, characterized by a pronounced lack of enthusiasm, motivation, or interest, is a predictor of the future onset of ...
JAN 19, 2021
Clinical & Molecular DX
Fathers' Sperm Linked to Autism in Offspring
JAN 19, 2021
Fathers' Sperm Linked to Autism in Offspring
Researchers at Washington State University have uncovered a genetic link between fathers and children with autism spectr ...
FEB 25, 2021
Clinical & Molecular DX
A Better Way to Triage COVID Patients
FEB 25, 2021
A Better Way to Triage COVID Patients
Australian researchers have developed a COVID-19 triaging tool that serves as a crystal ball for healthcare workers. Onc ...
Loading Comments...